A groundbreaking study has unveiled the significant benefits of using apixaban, a common blood thinner, for patients with a hard-to-detect type of atrial fibrillation.
This finding has major implications for stroke prevention in at-risk individuals.
Hidden Heart Condition and Stroke Risk
The focus of the study, led by Jeff Healey from the Population Health Research Institute, was on sub-clinical atrial fibrillation (SCAF), a form of irregular heartbeat not usually identified through standard heart tests.
Unlike the more recognizable clinical atrial fibrillation, SCAF often goes unnoticed, increasing the risk of stroke and blood clots in patients.
The study, spanning eight years and involving over 4,000 participants across 16 countries, showed that apixaban effectively reduces these risks.
The Impact of Apixaban
Apixaban, an oral anticoagulant, demonstrated a 37% reduction in the risk of stroke and clotting, and an impressive 49% decrease in fatal or disabling strokes among patients with device-detected atrial fibrillation.
While there was a noted increase in major bleeding, these incidents were mostly non-fatal and reversible, highlighting the drug’s overall safety and efficacy.
The results, published in the New England Journal of Medicine and presented at the American Heart Association Scientific Sessions, provide a strong case for considering apixaban in patients with SCAF and stroke risk factors.
Broader Implications for Cardiac Health
The significance of this study extends beyond its immediate findings.
As Dr. Healey points out, the growing use of implanted and wearable cardiac monitors, including consumer devices like the Apple Watch, means more people at risk could be identified and treated effectively.
The research paves the way for a future where disabling and fatal strokes can be prevented more efficiently in a broader population.
The study was a collaborative effort funded by several prestigious institutions, including the Canadian Institutes for Health Research and the Bristol-Myers Squibb-Pfizer Alliance.
Its implications are far-reaching, potentially transforming how doctors treat patients with hidden heart conditions and prevent strokes.
If you care about stroke, please read studies that diets high in flavonoids could help reduce stroke risk, and MIND diet could slow down cognitive decline after stroke.
For more information about nutrition, please see recent studies about antioxidants that could help reduce the risk of dementia, and tea and coffee may help lower your risk of stroke, dementia.
The research findings can be found in New England Journal of Medicine.
Copyright © 2023 Knowridge Science Report. All rights reserved.
